153 related articles for article (PubMed ID: 6101249)
1. Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).
Richerson HB; Suelzer MT; Swanson PA; Butler JE; Kopp WC; Rose EF
Am J Pathol; 1982 Mar; 106(3):409-20. PubMed ID: 6101249
[TBL] [Abstract][Full Text] [Related]
2. The local and systemic IgA and IgG antibody responses of rabbits to a soluble inhaled antigen: measurement of responses in a model of acute hypersensitivity pneumonitis.
Butler JE; Swanson PA; Richerson HB; Ratajczak HV; Richards DW; Suelzer MT
Am Rev Respir Dis; 1982 Jul; 126(1):80-5. PubMed ID: 7091913
[TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
4. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
Tanaka A; Emori K
Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407
[TBL] [Abstract][Full Text] [Related]
5. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
6. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine immunomodulation in a rabbit model of chronic hypersensitivity pneumonitis.
Kopp WC; Dierks SE; Butler JE; Upadrashta BS; Richerson HB
Am Rev Respir Dis; 1985 Nov; 132(5):1027-33. PubMed ID: 4062034
[TBL] [Abstract][Full Text] [Related]
8. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
Lowy I; Theze J; Chedid L
J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
[TBL] [Abstract][Full Text] [Related]
10. Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freund's incomplete adjuvant.
Kuroe K; Haga Y; Funakoshi O; Mizuki I; Kanazawa K; Yoshida Y
J Gastroenterol; 1995 Aug; 30(4):472-7. PubMed ID: 7550857
[TBL] [Abstract][Full Text] [Related]
11. Acute hypersensitivity pneumonitis: serial changes in lung lymphocyte subopulations after exposure to antigen.
Bernardo J; Hunninghake GW; Gadek JE; Ferrans VJ; Crystal RG
Am Rev Respir Dis; 1979 Nov; 120(5):985-94. PubMed ID: 315742
[TBL] [Abstract][Full Text] [Related]
12. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
13. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
[TBL] [Abstract][Full Text] [Related]
14. Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy.
Bahr GM; Modabber FZ; Rook GA; Mehrotra ML; Stanford JL; Chedid L
Clin Exp Immunol; 1982 Jan; 47(1):53-8. PubMed ID: 6807589
[TBL] [Abstract][Full Text] [Related]
15. In vivo responses to inhaled proteins. II. Induction of interstitial pneumonitis and enhancement of immune complex-mediated alveolitis by inhaled concanavalin A.
Willoughby WF; Willoughby JB; Cantrell BB; Wheelis R
Lab Invest; 1979 Mar; 40(3):399-414. PubMed ID: 423530
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
[TBL] [Abstract][Full Text] [Related]
17. Uptake of muramyl dipeptide by alveolar macrophages in experimental hypersensitivity pneumonitis.
Richerson HB; Adams P; Iwai Y; Barfknecht CF
Am J Ind Med; 1990; 17(1):120. PubMed ID: 2305780
[No Abstract] [Full Text] [Related]
18. Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits.
Langford MP; Foreman BD; Srur L; Ganley JP; Redens TB
Exp Eye Res; 2013 Nov; 116():324-36. PubMed ID: 24135297
[TBL] [Abstract][Full Text] [Related]
19. Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever.
Bahr GM; Majeed HA; Yousof AM; Chedid L; Behbehani K
J Infect Dis; 1986 Dec; 154(6):1012-7. PubMed ID: 3782865
[TBL] [Abstract][Full Text] [Related]
20. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA; Elin RJ; Chedid L; Wolff SM
J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
